
NVST — Envista Holdings Corp
NYSE · Healthcare · Medical Instruments & Supplies
$27.16
+$0.04 (+0.13%)
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on NYSE. It is led by Paul A. Keel, based in Building E, Brea, CA, United States, 92821-6208, with about 12,000 employees. Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Latest reported NVST revenue for 2025-09-26 was $669.9M. Net income was -$30.3M. Revenue was down 1.8% from 2025-06-27 to 2025-09-26. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Use this NVST page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NVST quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NVST SEC filings page. Lician reads the product cache first so this HTML stays unique to Envista Holdings Corp even when a live quote feed is slow.
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
NVST Key Statistics
Market Cap
$3.72B
P/E Ratio
55.78
Employees
12,000
Envista Holdings Corp Company Information
- CEO & Director
- Paul A. Keel
- Headquarters
- Building E, Brea, CA, United States, 92821-6208
- Website
- envistaco.com
- Phone
- 714 817 7000
- IPO / Founded
- 2019-09-18
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies